Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine
Journal of Cheminformatics volume 4, Article number: P47 (2012)
Vaccination is considered to be most effective way of fighting infectious diseases like malaria etc . N, N, N-trimethylchitosan (TMC) was synthesized from chitosan. Nanoparticles of the TMC were prepared in various media (milliQ water, Na2CO3 (pH 10.92), Na2HPO4 (pH 9.01) and alhydrogel® beads which were characterized as adjuvant for possible vaccine delivery. The nanoparticles were analyzed using microscopy (Phase contrast microscope and Confocal laser scanning microscope), and Malvern zetasizer Nano- ZS. Time-resolved particle size analysis was performed after one month storage of the TMC nanoparticles at 4 °C. The result of the study showed that PBS was the best medium that produced cationic, monodispersed and stable TMC nanoparticles of less than 65 nm forming a compatibly homogeneous system even upon storage. Microscopy of the polyelectrolyte doped nanoparticles showed a clear coating due to PSS at the periphery of the particles and a fluorescent core with some tiny central hollow cavities Confocal microscopy of the alhydrogel beads showed particle size of 1.6 µm. The fluorescent dye (PSSRhodamine) coated the entire particle surface suggesting a more or less adsorption process for the antigen delivery . Hence, the hope of nanocarrier for malaria vaccine.
Kammona O, et al: Nanocarrier Aided Nasal Vaccination: An Experimental and Computational Approach. Ind Eng Chem Res. 2011, 50: 590-601. 10.1021/ie100307t.
Ajay P, et al: A review on novel lipid based nanocarriers. Int J Pharm and Pharm Sci. 2010, 2: 30-35.
About this article
Cite this article
Nnamani, P.O., Nwodo, N.J. & Giacinto, S. Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine. J Cheminform 4 (Suppl 1), P47 (2012). https://doi.org/10.1186/1758-2946-4-S1-P47